These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 599084)

  • 41. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.
    Muñoz Bellido JL; Muñoz Criado S; García García I; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2612-5. PubMed ID: 9420028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensitivity to carbenicillin and ticarcillin, and the beta-lactamases of Pseudomonas aeruginosa in the UK in 1978-79.
    King JD; Farmer T; Reading C; Sutherland R
    J Clin Pathol; 1980 Mar; 33(3):297-301. PubMed ID: 6769973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin.
    Phaneuf D; Neu HC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):625-30. PubMed ID: 118706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods.
    Parry MF; Neu HC
    Antimicrob Agents Chemother; 1976 Apr; 9(4):625-32. PubMed ID: 817662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
    Wald ER; Standiford HC; Tatem BA; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1975 Mar; 7(3):336-40. PubMed ID: 806263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The in-vitro activity of mezlocillin against community hospital isolates in comparison to other penicillins and cephalosporins.
    Parry MF; Folta D
    J Antimicrob Chemother; 1983 May; 11 Suppl C():97-102. PubMed ID: 6619043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.
    Jacobs MR; Kelly F; Speck WT
    Antimicrob Agents Chemother; 1982 Nov; 22(5):897-900. PubMed ID: 6758692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro action of carbenicillin against bacteria isolated from clinical material.
    Isenberg HD; Siegel M
    Appl Microbiol; 1969 Sep; 18(3):387-92. PubMed ID: 4392088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.
    Thabaut A; Durosoir JL; Saliou P
    Infection; 1982; 10 Suppl 3():S249-56. PubMed ID: 7152690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.
    Neu HC; Fu KP; Aswapokee N; Aswapokee P; Kung K
    Antimicrob Agents Chemother; 1979 Aug; 16(2):150-7. PubMed ID: 314775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative in vitro activity of piribenicillin, ticarcillin, and carbenicillin against Pseudomonas aeruginosa.
    Murakawa T; Sabath LD
    Antimicrob Agents Chemother; 1977 Jan; 11(1):1-6. PubMed ID: 13704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistant strains of Pseudomonas aeruginosa isolated after exposure to several beta-lactam antibiotics.
    Hoekstra JL; de Neeling AJ; van Klingeren V; Stobberingh EE; van Boven CP
    Eur J Clin Microbiol; 1987 Feb; 6(1):22-7. PubMed ID: 3106033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
    Jacobs MR; Aronoff SC; Johenning S; Yamabe S
    J Antimicrob Chemother; 1986 Aug; 18(2):177-84. PubMed ID: 3019984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes.
    Basker MJ; Edmondson RA; Sutherland R
    Infection; 1979; 7(2):67-73. PubMed ID: 108220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG; Stilwell GA; Turck M
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
    Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
    Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative evaluation of piperacillin in vitro.
    Dickinson GM; Cleary TJ; Hoffman TA
    Antimicrob Agents Chemother; 1978 Dec; 14(6):919-21. PubMed ID: 253573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.